Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1397-1404

  Diaz, Bruno L ^a   Fujishima, Hiroshi ^a   Kanaoka, Yoshihide ^a   Urade, Yoshihiro ^a   Arm, Jonathan P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 17 TRINORPROSTAGLANDIN E2; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; BUTAPROST; DOCEBENONE; INTERLEUKIN 10; INTERLEUKIN 6; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN SYNTHASE; RECOMBINANT INTERLEUKIN 1BETA; STEM CELL FACTOR; SULPROSTONE; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTHRITIS; ARTICLE; BONE MARROW CELL; DOSE RESPONSE; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036467330     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1397     Document Type: Article

References (69)

1. The role of mast cells and basophils in inflammation
2. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
3. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis
4. Mast cells, eosinophils and fibrosis
5. Critical protective role of mast cells in a model of acute septic peritonitis
6. 4 from a subclass of mast cells differentiated in vitro from mouse bone marrow
7. 2 and 5-lipoxgenase
8. Release of chemical mediators from partially purified human lung mast cells
9. 2 in mouse bone marrow-derived mast cells
10. 2 generation via prostaglandin endoperoxide synthase-2
11. 2 in activated mast cells
12. 2 production in mast cells
13. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines
14. Mast cell lines produce lymphokines in response to crosslinking of FcεR1 or to calcium ionophores
15. Production of the haemopoetic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation
16. Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation
17. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
18. Post-transcriptional stabilization by interleukin-1Β of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells
19. 2 is essential for the immediate and delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells
20. Cloning and crystal structure of hematopoietic prostaglandin D synthase
21. Mast cells contain spleen-type prostaglandin D synthetase
22. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene
23. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2
24. Feedback control of cyclooxygenase-2 expression through PPAR γ
25. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
26. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
27. 2) autoamplifies its production through EP1 - Subtype of PGE receptor in mouse osteoblastic MC3T3-EI cells
28. 2 upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages
29. 2: Distinct roles of cyclooxygenase-1 and -2
30. 2 production
31. 2
32. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
33. 2 generation in immature mouse mast cells
34. Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell
35. Prostanoid receptors: Structures, properties, and functions
36. 2
37. 2, cyclic AMP and non-steroidal anti-inflammatory drugs
38. 2
39. A new view of prostaglandin E regulation of the immune response
40. 2 regulation of the immune response
41. Prostaglandins, arachidonic acid, and inflammation
42. Modulation of T-cell cytokine secretion by accessory cell-derived products
43. + T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5
44. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
45. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
46. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
47. 2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia
48. Inducible cyelooxygenase may have anti-inflammatory properties
49. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells
50. 2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism
51. Induction of cyclooxygenase-2 in alveolar macrophages after acid aspiration: Selective cyclooxygenase-2 blockade reduces interleukin-6 production
52. 2 in a murine model of inflammation: Possible role of cyclooxygenase-2
53. 2 in normal and asthmatic men
54. 2 as a mediator of allergic asthma
55. Defective inflammatory response in interleukin 6-deficient mice
56. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
57. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation
58. Heterogeneity of human mast cells based on cytokine content
59. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-II and IL-6 in the lung
60. 4 excretion in aspirin-sensitive asthma
61. Altered bronchodilation and pulmonary inflammation in prostanoid EP2 receptor knockout mice
62. 2: Anti-tumour and anti-viral activities and the mechanisms involved
63. 2 is a ligand for the adipocyte determination factor PPAR γ
64. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
65. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12.13-myristate-type tumor promoters in immortalized mouse liver cells
66. 2
67. 2 inhibits multiple steps in the NF-κB signaling pathway
68. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
69. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation